GLO1 and obesity due to melanocortin 4 receptor deficiency: In the last decades, the modulation studies of GLYI expression/activity have received growing attention in mammalian systems for the key role of this enzyme in obesity, diabetes, cardiovascular diseases, chronic renal failure, cancer, neurological disorders (Rabbani et al., 2016).